AC Immune (ACIU) Profit After Tax Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | 10.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.70% |
| Dec 31, 2025 | 0.27% |
| Sep 30, 2025 | -412.11% |
| Jun 30, 2025 | -1.69% |
| Mar 31, 2025 | -3.42% |
| Dec 31, 2024 | -237.17% |
| Sep 30, 2024 | 137.05% |
| Jun 30, 2024 | -34.43% |
| Mar 31, 2024 | -8.08% |
| Dec 31, 2023 | 72.52% |
| Sep 30, 2023 | -22.50% |
| Jun 30, 2023 | 8.21% |
| Mar 31, 2023 | 7.22% |
| Dec 31, 2022 | 15.65% |
| Sep 30, 2022 | 19.27% |
| Jun 30, 2022 | 2.47% |
| Mar 31, 2022 | -10.27% |
| Dec 31, 2021 | -6.97% |
| Sep 30, 2021 | 15.98% |
| Jun 30, 2021 | -28.03% |
| Mar 31, 2021 | -132.84% |
| Dec 31, 2020 | -9.78% |
| Sep 30, 2020 | -211.63% |
| Jun 30, 2020 | 3.09% |
| Mar 31, 2020 | -112.45% |
| Dec 31, 2019 | -33.22% |
| Sep 30, 2019 | 234.56% |
| Jun 30, 2019 | -48.87% |
| Mar 31, 2019 | 621.26% |
| Dec 31, 2018 | -449.46% |
| Sep 30, 2018 | -50.32% |
| Jun 30, 2018 | 9.52% |
| Mar 31, 2018 | -30.04% |
| Dec 31, 2017 | 155.33% |
| Sep 30, 2017 | 2.04% |
| Jun 30, 2017 | -194.11% |
| Mar 31, 2017 | -51.45% |
| Dec 31, 2016 | -35.18% |
| Sep 30, 2016 | -144.72% |